Study shows muscle tissue grown from stem cells can repair heart damage
May, 2012 — A Japanese research team has developed a promising new treatment for heart failure by growing sheets of new heart muscle tissue from stem cells. When implanted in damaged rat hearts, the bioengineered tissue improved heart function.
Stem Cell Scientists Boost Cell Survival in Adipose Tissue Transplantations
Durham, NC (March 2012) – A new study by a team of researchers at Tor Vergata University of Rome reveals a way to improve the long-term results in patients receiving fat grafts to correct soft tissue defects. Their work was released today in STEM CELLS Translational Medicine.
Stem Cell-Seeded Cardiopatch Could Deliver Results for Damaged Hearts
Durham, NC (March 2012) – A new type of stem cell-seeded patch has shown promising results in promoting healing after a heart attack, according to a study released today in the journal STEM CELLS Translational Medicine.
New production method could fill major need for new sources of MSCs
Durham, NC – Stem cell scientists from the University of Queensland Centre for Clinical Research (UQCCR) in Australia have discovered a new method for producing mesenchymal stem/stromal cells (MSCs) from human iPSCs that substantially improves on current methods and speeds up conversion time. The research, published today in STEM CELLS Translational Medicine, reveals that treating iPSCs with the transforming growth factor-ß pathway inhibitor SB431542 leads to rapid and uniform MSC conversion of pluripotent stem cells without the need for embryoid body formation or feeder cell co-culture.
Study shows cardiac stem cells outperform bone marrow stem cells in treating heart attacks
Durham, NC – A new study by collaborating researchers at the University of Miami Miller School of Medicine and L’Institut du Thorax in Nantes, France, indicates that stem cells derived from cardiac tissue are far more effective in repairing damage caused by a heart attack than therapies using stem cells taken from bone marrow. The study, published today in STEM CELLS Translational Medicine, suggests that human fetal cardiac-derived c-kit+ stem cells (CSCs) can be 30 times more potent than bone marrow mesenchymal stem cells (MSCs) for treating a heart attack.
